Publication | Closed Access

Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy: A focus on anti PD-1/PD-L1 antibodies

Cancer ImmunosurveillanceAnti Pd-1/pd-l1 AntibodiesMedicineImmunologyTherapeutic VaccineImmune Checkpoint InhibitorImmune Cell TherapyImmunotherapyOncologyRadiation OncologyCar-t Cells